An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

NCT05876754 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholangiocarcinoma

Interventions

DRUG: Ivosidenib Oral Tablet

Sponsor

Servier Affaires Médicales